Profitability
Weight: 20%
C
51
- 5yr Avg ROIC 11.6%
- Operating Margin Trend -1.39 pp/yr
EW
Edwards Lifesciences Corporation
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
A
88
- 5yr Avg ROE 18.7%
- 5yr Share-Count CAGR -1.8%
Growth Quality
Weight: 15%
D+
41
- 5yr Revenue CAGR 3.8%
- 5yr EPS CAGR -6.4%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 15%
B+
75
- 5yr FCF Margin 16.9%
- 5yr FCF/NI Conversion 0.66x
Balance Sheet
Weight: 20%
A+
100
- Net Debt / EBITDA -2.46x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 12.37
Stability
Weight: 15%
D+
43
- EPS Volatility (σ/μ) 0.85
- Piotroski F-Score 6
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 3 added; 1 trimmed; 1 full exit.
- Holders
- 4
- Avg Δ position
- +44.6%
- New buys
- 0
- Full exits
- 1
- Cooperman sold -100%
- Dalio increased +124%
- Greenblatt increased +88%